SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-117445
Filing Date
2016-08-09
Accepted
2016-08-09 09:01:40
Documents
65
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v445006_10q.htm 10-Q 404258
2 EXHIBIT 31.1 v445006_ex31-1.htm EX-31.1 9955
3 EXHIBIT 31.2 v445006_ex31-2.htm EX-31.2 10036
4 EXHIBIT 32.1 v445006_ex32-1.htm EX-32.1 3804
5 EXHIBIT 32.2 v445006_ex32-2.htm EX-32.2 3725
  Complete submission text file 0001144204-16-117445.txt   3895767

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sbot-20160630.xml EX-101.INS 886422
7 XBRL TAXONOMY EXTENSION SCHEMA sbot-20160630.xsd EX-101.SCH 41626
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbot-20160630_cal.xml EX-101.CAL 38120
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbot-20160630_def.xml EX-101.DEF 221621
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbot-20160630_lab.xml EX-101.LAB 298687
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbot-20160630_pre.xml EX-101.PRE 264086
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Stellar Biotechnologies, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1029
Type: 10-Q | Act: 34 | File No.: 001-37619 | Film No.: 161816326
SIC: 2834 Pharmaceutical Preparations